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Sucrose polyester does not inhibit gastric acid secretion or 
stimulate cholecystokinin release in men1-3
Monique IM Maas, Wim PM Hopman, Thea van der Wijk, Marlijn B Ka tan, and Jan BMJ Jansen
ABSTRACT Replacement of dietary lilt by sucrose polyester 
reduces fat intake. However, little is known about the effccts of 
sucrose polyester on gastrointestinal function. To investigate the 
effect on gastric acid secretion and on release of cholecystokinin 
into plasma, we perfused eight healthy male volunteers intraduo- 
denally with sucrose polyester, digestible fat, or saline on separate 
days in random order, Intraduodenal perfusion of sucrose polyester 
did not suppress gastrin-stimulated gastric acid secretion ( — 1.8 ± 
6,8%) whereas digestible fat suppressed gastric acid secretion by 
64 ± 9% (P = 0.001) compared with saline. Sucrose polyester did 
not affect plasma cholecystokinin concentrations (-12.8 ± 9.3 
pmol • 30 min/L) whereas perfusion with digestible fat resulted in 
a significant increase (31.7 ±  9.3 pmol -30 min/L, P ~  0,017) 
compared with saline. We conclude that sucrose polyester, in 
contrast with digestible fat, does not inhibit gastrin-stimulated 
gastric acid secretion or stimulate release of cholecystokinin, 
Am J Clin Nutr 1997;65:761-5.
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Stimulation of plasma CCK and pancreaticobiliary secretion 
by fatty nutrients depends on the presence of the products of fat 
digestion in the proximal small intestine (23-29). The inhibi­
tion of gastric acid secretion by fat might dopend on (he 
digestion of fat as well.
We report the effect of digestible fat and the indigestible fat 
sucrose polyester on gastric acid secretion and on CCK release 
in men.
SUBJECTS AND METHODS 
Subjects
Eight healthy, nonsmoking, male volunteers aged 20-26 y 
participated in the studies. Body mass indexes (in kg/m2) 
ranged from 22 to 29. None of the subjects had a history of 
gastrointestinal diseases or surgery and none was taking any 
medication, The study protocol was approved by the Medical 
Ethical Committee of the University Hospital Nijmegen and 
written informed consent was obtained from each volunteer.
INTRODUCTION Materials
Lowering dietary fat intake is thought to have beneficial 
effects on health (1, 2). One way to achieve this goal is to 
replace dietary fat with a nondigestible fat of comparable 
texture such as sucrose polyester. Sucrose polyester is a mix­
ture of hexa-, hepta-, and octaesters of sucrose. It is not 
hydrolyzed by pancreatic lipases so it is not absorbed from the 
intestine (3). Recently, the sucrose polyester olestra was ad­
mitted as a food ingredient in the United States for the prepa­
ration of chips and snacks.
Digestible fat and sucrose polyester may differ in their 
effects on gastrointestinal functions such as gastric emptying, 
gastric acid secretion, gallbladder motility, or pancreatic exo­
crine function. Therefore, long-term use of sucrose polyester 
might conceivably have clinical effects in disorders such as 
reflux esophagitis (4-7). Ordinary digestible fat is a potent 
inhibitor of gastric acid secretion (8-10). Decreased suppres­
sion of gastric acid secretion by sucrose polyester may affect 
symptoms in acid-related disorders.
Digestible fat is a powerfu 1 stiinu 1 us for plasma cholecysto­
kinin (CCK) release and subsequently for gallbladder contrac­
tion and pancreatic enzyme secretion (11-17). It has been 
suggested that the inhibition of gastric acid secretion is also 
mediated at least in part by CCK (8-10, 18-22).
uonsulfated gastrin-17 was 
Cambridge Research Biochemicals (Cheshire, United King­
dom). It was dissolved under aseptic conditions in saline con­
taining 2% human serum albumin and stored at — 20 °C. Syn­
thetic human CCK (CCK3:,) was purchased from Peninsula 
Laboratories (St Helens, United Kingdom). Digestible fat 
(Gold flex), containing 12% pal mi late, 9% stearate, 54% oleate, 
and 23% linolcate was from Van den Bergh Professional BV 
(Rotterdam, Netherlands). Sucrose polyester containing 10% 
palmitale, 6% stearate, 35% oleate, and 44% linolcate was a 
gift from Unilever Research, Vlaardingen, Netherlands.
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Experimental design
Over I mo each subject underwent three experiments in 
random order on different days separated by ^  I wk, After an 
overnight fast, the volunteers arrived at the gastrointestinal 
research laboratory at 0800, A single-lumen polyvinyl perfu­
sion catheter for the administration of fats or saline was placed 
into the proximal duodenum under fluoroscopic control. A 
polyvinyl gastric drainage tube was placed into the stomach 
together with a small-bore polyethylene perfusion catheter 
inserted into one of the three side holes of the gastric drainage 
tube. The position of this tube was checked by the water 
recovery method (30); subsequently, the small-bore catheter 
was pulled back ^  10 cm to release it from the drainage tube. 
The stomach was emptied and then perfused with a saline 
solution containing 3 mg phenol red/L at a rate of 120 mL/15 
rain. Gastric contents were aspirated continuously during the 
experiments by using a suction pump that provided intermittent 
negative pressure. The gastric aspirates were collected in 15- 
rain portions and kept on ice.
Indwelling intravenous catheters were placed into the left 
and right forearm of each subject. The catheters were kept 
patent with a saline solution. One catheter was used for the 
collection of blood samples and the other for the infusion of 
nonsulfated gastrin-17 at a dose of 10 pmol * kg™1 • h™1. This 
dose produces plasma gastrin concentrations similar to those 
found after a meal (31). Blood samples were taken every 30 
min during the 1-h basal period and every 15 min during the 
subsequent gastrin-infusion period. Blood samples were col­
lected into ice-chilled 10-mL glass tubes containing 15 mg 
EDTA.
Four 15-min gastric samples were collected under unstimu­
lated conditions. Subsequently, the intravenous gastrin-17 in­
fusion was started and continued for 3 h. After 1 h of gastrin 
infusion, 30 mL of either saline, sucrose polyester (containing 
92.9 mmol fatty acids), or digestible fat (containing 93.4 mmol 
fatty acids) was perfused intraduodenally at a rate of 20 mL/h 
for 90 min* This was followed by a 30-min period during which 
no fat was perfused.
Immediately after the experiments the blood samples were 
centrifuged for 15 min at 4000 rpm, 2560 X at room 
temperature and plasma was stored at —20 °C. The volume and 
pH of each 15-min gastric juice sample was recorded, and the 
hydrogen ion concentration was determined by titration to pH
7,0 with 0.1 mo 1 NaOH/L. Then the gastric samples were 
centrifuged for 1 min at 12 000 X # and the supernate was 
alkalized with 2,5 mol NaOH/L, after which the concentration 
of phenol red was measured spectrophotometrically at 560 nm, 
Recovery of gastric juice was calculated by the following 
equation:
(VA X ABSa )/(Vp X ABSp) U)
where VA represents the volume of aspirated gastric juice, 
ABSa the phenol red absorption of the aspirated gastric juice, 
Vr> the volume of phenol red solution perfused into the stom­
ach, and ABSp the phenol red absorption of the perfused 
solution, each per 15-min period. The amount of acid secreted 
(mmol/15 min) was calculated as follows:
Plasma gastrin and CCK concentrations were measured by 
sensitive and specific radioimmunoassays as described previ­
ously (32-35),
Data analysis
Results are expressed as means ± SEMs unless stated oth­
erwise. Basal gastric acid output was defined as the sum of the 
last two 15-min portions obtained under unstimulated condi­
tions [/ = -1 5  min (i_i5) + ?(>]. Gastrin-stimulated gastric acid 
output was defined as the sum of the last two 15-min portions 
obtained during the first hour of gastrin-17 infusion (/4fi H- im), 
The percentage inhibition of gastric acid secretion by saline, 
sucrose polyester, or digestible fat was calculated as follows:
(/45 >1* /60) -  (/ 135 + 1150)
/45 H- ¿60
X 100% (3)
where t45 -F tM) represents the final 30 min before fat perfusion 
and /,35 + /,50 the gastric acid secretion over the final 30 min 
of the fat-perfusion period. Integrated plasma CCK concentra­
tions for the last 30 min of each experimental period were 
calculated as area under the plasma concentration-versus-time 
curves by using the trapezoidal rule. Statistical analysis was 
performed by two-way analysis of variance (ANOVA) for 
repeated measurements and the two-tailed / test for paired 
results, SPSS 5.0 (SPSS, Benelux BV, Gorinchem, Nether­
lands) was used for statistical analysis.
RESULTS
Plasma gastrin concentrations
Infusion of gastrin increased plasma gastrin concentrations 
from a basal concentration of 23 ± 3 to 55 ± 5 pmol/L in the 
saline experiment, from 23 ± 2 to 54 ± 3 pmol/L in the 
sucrose polyester experiment, and from 26 ± 4 to 51 ± 3  
pmol/L in the digestible-fat experiment. Subsequent duodenal 
perfusion of sucrose polyester or digestible fat during gastrin 
infusion did not further affect plasma gastrin concentrations.
Gastric acid secretion
The initial infusion of gastrin raised gastric acid output in all 
experiments to a similar extent (Figure 1), Subsequent in- 
traduodenal perfusion of sucrose polyester did not suppress 
acid secretion in contrast with digestible fat, which suppressed 
gastrin-stimulated gastric acid secretion by 64,2 ± 8,8% (P ~ 
0.001, Table 1) relative to saline.
Plasma cholecystokinin concentrations
Perfusion of sucrose polyester had no significant effect oil 
plasma CCK (Figure 2). Perfusion of digestible fat resulted in 
significantly (P ~  0,017) higher integrated plasma CCK con­
centrations than did saline (Table 2).
(Acid concentration measured X VA)/rccevery (2)
DISCUSSION
This study showed that the nondigestiblc fat sucrose poly“ 
ester cannot inhibit gastrin-stimulated gastric acid secretion or 
stimulate the release of CCK. In contrast, digestible fat signif­
icantly inhibited gastric acid secretion and augmented CCK 
release. The key difference between sucrose polyester and
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FIGURE 1. Mean (± SEM) gastric acid output in eight volunteers 
under basal conditions and during intravenous infusion of gastrin (10 
pmol • kg“ 1 • h " 1), subsequently combined with an intraduodenal perfu­
sion of digestible fat (62 mmol/h; A), sucrose polyester (62 mmol/h; □), or 
saline (20 mL/h; • ) .
Time (min)
FIGURE 2. Mean (± SEM) plasma cholccystokinin (CCK) concentra­
tions in eight volunteers under basal conditions and during intravenous 
infusion of gastrin (10 pmol * kg '“1 • h“ 1), subsequently combined with an 
intraduodenal perfusion of digestible fat (62 mmol/h; A)» sucrose polyester 
(62 mmol/h; □), or saline (20 mL/h; • ) .
regular fats is that the fatty acicls in sucrose polyester cannot be 
split off by pancreatic lipases (36-38). This might be the reason 
for the absence of plasma CCK secretion and suppression of 
gastric acid secretion in response to sucrose polyester. CCK 
may be involved in the suppression of gastric acid secretion by 
intraduodenal fat (18-22), although we showed that suppres­
sion of acid secretion can be reached by medium-chain tria- 
cylglycerols without concomitant CCK release (39). The in­
crease of plasma CCK in response to digestible fat was
TABLE 1
Gastric acid output in (he stomach before gastrin infusion (basal), during 
gastrin infusion, and during intraduodenal perfusion of sucrose polyester 
(SPE), digestible fat, or saline in eight volunteers; intravenous gastrin 
infusion was continued during the intraduodenal perfusion of fat7
Treatment
Gastric acid output
Basal
Gastrin + 
Gastrin saline or fat Change’
mmol/30 mm mmol/30 min mmol/30 min %
Saline 3.1 ±  0.7 9.1 ± 1.3 9.6 ± 1.1 9.7 ± 8.3
SPE 2.7 ± 1.0 8.6 ± 1.3 8.2 ± 1.3 -  L8 ± 6.8
Digestible fat 1.6 i  0.7 8.6 ± 1.6 3.0 ± 0.9 -64.2 ± 8.K-'
1 X ± V,
2 The effect of fat perfusion relative to gasirin infusion alone. 
•'Significantly different from other treatments, P 0,001.
probably of physiologic significance because we have found 
that plasma CCK increments during fat perfusion in the same 
range as in the present study stimulated gallbladder contraction 
(14, 40) and delayed gastric emptying (41, 42).
Recent studies suggest that hydrolysis of friacylglycerols, 
resulting in the release of fatty acids and monoaeylglycerols, is 
an important prerequisite for appropriate stimulation of plasma 
CCK (23-29). Plasma CCK secretion and gallbladder empty-
TABLE 2
Integrated plasma eholceystokinin concentrations before intravenous 
gastrin infusion (basal), during intravenous gastrin infusion, and during 
additional intraduodenal perfusion of sucrose polyester (SPE), digestible 
fat, or saline in eight volunteers; ini ravenous gastrin infusion was 
continued during the intraduodenal perfusion of lat;
«n*
Plasma cholccystokinin
Basal Gastrin
Gastrin 1' 
saline or fat Change*'
pmol •  30 min/h
Saline
SPE
Digestible fat
91.5 Æ 4.7
100.5 ±: 5.3 
81.9 ± 3.9
83.9 ± 7.3 
89.5 ± 5.0 
81,4 ±  6.3
79.3 ± 8.9 
76.8 ± 8.0 
113.1 ± 6.4
-4 ,6  £  7.0 
■12.8 ± 9.3 
31.7 ± 9,3’'
1 .V :t SEM.
“ The effect of fat perfusion relative to gastrin infusion alone. 
■* Significantly different from other treatments, P Ss 0.02.
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ing in response to a meal were reduced in patients with pan­
creatic insufficiency (23, 24), whereas addition of pancreatic 
enzymes to the meal normalized the impaired responses. In 
contrast with undigested corn oil, corn oil that had been pre­
digested with bile and pancreatic juice induced plasma CCK 
secretion and gallbladder contraction in patients with untreated 
celiac disease (25, 26). Furthermore, it was shown that the 
lipase inhibitor orlistat inhibited biliary and pancreatic output 
and increased postprandial gastric acidity (27,28). Animal data 
also point to the necessity of digestion of fat for gastric acid 
secretion or pancreatic enzyme release (29, 43, 44). In humans 
it was shown that oleic acid inhibited gastric acid secretion 
whereas oleyl alcohol did not (45), indicating that the free 
carboxyl group of the fatty acid molecule has an important role 
in the inhibition of gastric acid secretion. Because the carboxyl 
groups of the fatty acids in sucrose polyester remain esterified, 
the results of the present study supply further evidence that the 
products of fat digestion play an important role in the intestinal 
phase of plasma CCK secretion and gastric acid suppression in 
humans.
The finding that sucrose polyester does not inhibit gastric 
acid secretion and does not release CCK into the plasma may 
have clinical implications. On the one hand, gastric acid may 
play a role in the pathogenesis of gastroesophageal reflux 
disease (46,47). Both increased basal and food-stimulated acid 
secretion likely contribute to longer duration of esophageal 
acid exposure (5-7, 48). Increased aggressiveness of refluxed 
material owing to a lower gastric pH may potentiate the nox­
ious effects of refluxed gastric material and possibly of re­
fluxed bile (5, 6, 47-49).
On the other hand, substitution of ordinary fat by sucrose 
polyester may also affect other factors that are supposed to be 
involved in gastroesophageal reflux disease, including gastric 
emptying (50) and esophageal sphincter pressure (51-54). 
However, contradictory results have been published on the 
effects of sucrose polyester on gastric emptying (55, 56) and on 
the role of gastric emptying in reflux esophagitis (50). Fat has 
been shown to decrease esophageal sphincter pressure (57), 
which may result in gastroesophageal reflux (58). CCK, which 
is released by fat but not by sucrose polyester, may be the 
mediator of this lower esophageal sphincter relaxation (59, 60). 
The effect of sucrose polyester on the lower esophageal sphinc­
ter has not been studied yet as far as we know, but it has been 
shown that sucrose polyester decreases postprandial gastro­
esophageal reflux episodes and esophageal acid exposure (61).
The overall effect of sucrose polyester on gastroesophageal 
reflux disease is therefore unpredictable and further studies are 
needed to investigate the role of sucrose polyester on gastro­
esophageal reflux symptoms. We conclude that intraduodenal 
sucrose polyester, in contrast with regular fat, does not sup­
press the stimulated gastric acid secretion and does not stimu­
late plasma CCK release, probably because sucrose polyester is 
not digested, and therefore, no fatty acids or monoacylglycerols 
are released.
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